You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Diabetes and other endocrinal, nutritional and metabolic conditions
  5. Metabolic conditions

Fosdenopterin for treating molybdenum cofactor deficiency type A (terminated appraisal)

  • Technology appraisal
  • Reference number: TA1078
  • Published:  25 June 2025
  • Guidance
  • Tools and resources
  • History

On this page

  1. Declaration of interests
  2. Evaluation consultation
  3. Invitation to participate
  4. Topic selection
  5. Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators: 6264

History

Documents created during the development process.

Declaration of interests

  • Register of interests (PDF 102 KB)

    Published:
    09 April 2025

Evaluation consultation

  • Evaluation consultation

  • Draft guidance (downloadable version) (PDF 341 KB)

    Published:
    19 September 2024
  • Draft guidance (online commenting)

  • Committee papers (PDF 5.95 MB)

    Published:
    19 September 2024
  • Public committee slides (PDF 1.18 MB)

    Published:
    19 September 2024
  • Equality impact assessment (downloadable version) (PDF 144 KB)

    Published:
    19 September 2024

Invitation to participate

  • Final scope (PDF 145 KB)

    Published:
    22 November 2023
  • Final stakeholder list (PDF 164 KB)

    Published:
    22 November 2023
  • NICE's response to comments on the draft scope and provisional stakeholder list (PDF 451 KB)

    Published:
    22 November 2023
  • Equality Impact Assessment (Guidance development) (PDF 125 KB)

    Published:
    22 November 2023

Topic selection

  • Supporting documentation (MSWord 44 KB)

    Published:
    30 October 2023

Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators: 6264

  • Draft matrix post referral (PDF 164 KB)

    Published:
    26 July 2023
  • Draft scope post referral (PDF 155 KB)

    Published:
    26 July 2023
Back to top